Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BioLase Technology, Inc. (BLTI) -- Ignore unavailable to you. Want to Upgrade?

To: TokyoMex who wrote (222)	11/25/1997 12:34:00 PM
From: Karl Drobnic	Read Replies (1) \| Respond to of 706

TMEX: But not boring for much longer. Look at the 10Q for the wake up call. In the section on "Raw materials, work-in-progress, and finished goods", there is about $500,000. It is roughly divided into 1/3 for each category. Now if it takes BLTI an average 45 days to go from raw materials to finished goods, that's $1 million of product in the pipeline for 4Q. They did $600,000 in sales for 3Q. They've got $500,000 already in the pipeline at October 1. It is looking like a slam dunk for $1 million in 4Q if BLTI has solved some of the "production inefficiencies" they allude to in the 10Q. I think they either have, or are close to it. So $1 million is a 60% increase in sales. This story is developing very rapidly now.